VOYA Investment Management
RPRX

VOYA Investment Management’s Repros Therapeutics Inc. RPRX Stock Holding History

VOYA Investment Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-18,253
Closed -$157K – 2735
2015
Q1 		$157K Hold
18,253
– – ﹤0.01% 2484
2014
Q4 		$182K Hold
18,253
– – ﹤0.01% 2509
2014
Q3 		$181K Hold
18,253
– – ﹤0.01% 2517
2014
Q2 		$316K Hold
18,253
– – ﹤0.01% 2311
2014
Q1 		$324K Hold
18,253
– – ﹤0.01% 2276
2013
Q4 		$334K Buy
18,253
+3,945
+28% +$74.5K ﹤0.01% 2253
2013
Q3 		$383K Hold
14,308
– – ﹤0.01% 2109
2013
Q2 		$264K Buy
+14,308
New +$253K ﹤0.01% 2336

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCM
Destrier Capital Management New York $144M AUM 7.28% 1-Year Est. Return

VOYA Investment Management's RPRX Position: Q2 2015 in Review

VOYA Investment Management sold out of Repros Therapeutics Inc. (RPRX) in Q2 2015, closing a stake of 18,253 shares — an estimated $157K sold.

VOYA Investment Management first reported a position in RPRX in Q2 2013 and held it in 8 quarters. The position peaked at $383K in Q3 2013. 64 funds tracked by Wall St. Rank hold RPRX as of Q2 2015.

  • VOYA Investment Management reported no remaining Repros Therapeutics Inc. position as of Q2 2015 after selling out during the quarter.
  • VOYA Investment Management sold 18,253 Repros Therapeutics Inc. shares in Q2 2015, an estimated $157K.
  • VOYA Investment Management first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 8 quarters.
  • VOYA Investment Management's Repros Therapeutics Inc. position peaked at $383K in Q3 2013.
  • 64 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q2 2015.

Based on VOYA Investment Management's 13F filing for Q2 2015, filed 14 Aug 2015.